A science advisory from the American Heart Association recommended that prescription n-3 fatty acids (eicosapentaenoic acid [EPA]+docosahexaenoic acid [DHA] or EPA-only) at a dose of 4 g/d (>3 g/d total EPA+DHA) are an effective and safe option for reducing triglycerides as monotherapy or as an adjunct to other lipid-lowering agents (https://www.ahajournals.org/). AstraZeneca announced that compared to placebo, dapagliflozin (a SGLT2 inhibitor) significantly reduced cardiovascular death or the worsening of heart failure (HF, defined as hospitalization or an urgent HF visit) in patients with and without type 2 diabetes with reduced ejection fraction on standard of care treatment (https://www.astrazeneca-us.com/). Data from a US community‐based cohort of 12 168 middle‐aged adults suggest that diets higher in plant foods and lower in animal foods were associated with a lower risk of cardiovascular morbidity and mortality in a general population (https://www.ahajournals.org/).
A recent article explored the science and skepticism surrounding seed oils. These oils—extracted from sources…
A Canadian study of adults with high blood pressure (BP) found no difference in health…
Two randomized, controlled trials evaluated the efficacy and safety of obicetrapib, an oral cholesteryl ester…
A UK longitudinal associations study revealed that hyperlipidemias and inflammation independently and together raise the…
A study shows that eating a lot of highly processed foods is likely causing a…
Two recent studies highlight the importance of physical activity volume and intensity in reducing cardiovascular…
This website uses cookies.